Ceragenix Announces Results from Phase IV Study of EpiCeram(TM ... - Genetic Engineering News (press release)
The study, which took place at five centers, consisted of 113 pediatric patients, with 59 patients receiving treatment with Cutivate(R) and 54 patients ...